What new medications or therapies are currently under investigation?

To evaluate efficacy and safety of the anti-interleukin-23p19 monoclonal antibody tildrakizumab in patients with psoriatic arthritis (PsA). Jan 23, 2024 ... Background Information. Description. Psoriatic arthritis is a seronegative inflammatory spondyloarthropathy associated with mild to very severe ... conditions such as psoriasis, psoriatic arthritis, and axial ... They may differ from the information contained in this leaflet. Always use COSENTYX as ... Feb 17, 2024 ... Doctors continue to study the treatment and triggers for psoriasis. Some of the areas they're pursuing for future potential treatment are: gene ... Dec 23, 2024 ... ... informational purposes. Inclusion or exclusion of a procedure ... psoriasis and psoriatic arthritis. J Am Acad Dermatol. 2011; 65: 137 ... ... informational materials are also available on line; in 2005, approximately ... arthritis) that are among the most prevalent, costly, and preventable of ... Jun 10, 2021 ... As part of the Enterz system of informational retrieval, PubMed ... Journal of Psoriasis and Psoriatic Arthritis. ISSN: 2475-5303; Online ... Jan 15, 2025 ... Secukinumab injection is used to treat moderate to severe plaque psoriasis (a skin disease in which red, scaly patches form on some areas of the body) Assessing the Informational Needs of Adolescents and Young Adults with Rheumatic Disease 2024 ... Psoriatic Arthritis in a Phase 3 Pivotal Psoriasis Study 2018 ... Feb 8, 2021 ... ... rheumatoid arthritis, psoriatic arthritis and ulcerative colitis. However, there is increasing evidence that the drug makers failed to ...